Lisa G. Roth, MD (@lisaroth_md) 's Twitter Profile
Lisa G. Roth, MD

@lisaroth_md

Pediatric oncologist, lymphoma researcher, Hodgkin lymphoma survivor. Director of Pediatric Oncology @WeillCornell and @NYPhospital

ID: 2921974297

linkhttps://weillcornell.org/lgroth calendar_today07-12-2014 18:09:58

113 Tweet

438 Followers

205 Following

Lymphoma Research Foundation (@lymphoma) 's Twitter Profile Photo

The Lymphoma Research Foundation is proud to welcome four new members to our Scientific Advisory Board: Alex Herrera, MD (City of Hope), Kami Maddocks, MD (@osuccc_james), Todd Fehniger, MD, PhD (@wustl), and Gilles Salles, MD, PhD (@mskcancercenter): lymphoma.org/news/lymphoma-…

The Lymphoma Research Foundation is proud to welcome four new members to our Scientific Advisory Board: Alex Herrera, MD (<a href="/cityofhope/">City of Hope</a>), Kami Maddocks, MD (@osuccc_james), Todd Fehniger, MD, PhD (@wustl), and Gilles Salles, MD, PhD (@mskcancercenter): lymphoma.org/news/lymphoma-…
NatureRevClinOncol (@natrevclinoncol) 's Twitter Profile Photo

In this new article, we summarize results from the HD21 trial of first-line BrECADD vs eBEACOPP for advanced-stage classical Hodgkin lymphoma: nature.com/articles/s4157…

In this new article, we summarize results from the HD21 trial of first-line BrECADD vs eBEACOPP for advanced-stage classical Hodgkin lymphoma: nature.com/articles/s4157…
Petri Pölönen (@polonenpetri) 's Twitter Profile Photo

Interested in non-coding alterations, large-scale genomics, leukemia? Collaboration between Charles Mullighan and Teachey labs. Genomic analysis of >1300 WGS/WTS/WES samples from T-lineage acute lymphoblastic leukemia, out now in nature nature.com/articles/s4158… Highlights (7):

Paul Bröckelmann (@broeckelmannpj) 's Twitter Profile Photo

Just in time for #ISHL13 a comprehensive review on Hodgkin lymphoma biology and implications for translational research is now available Trends in Molecular Medicine, masterfully authored by Ralf Küppers Uni Duisburg-Essen @unidue.bsky.social #SFB1530 cell.com/trends/molecul…

Just in time for #ISHL13 a comprehensive review on Hodgkin lymphoma biology and implications for translational research is now available <a href="/TrendsMolecMed/">Trends in Molecular Medicine</a>, masterfully authored by Ralf Küppers <a href="/unidue/">Uni Duisburg-Essen @unidue.bsky.social</a> #SFB1530 cell.com/trends/molecul…
Paul Bröckelmann (@broeckelmannpj) 's Twitter Profile Photo

Grateful for the opportunity to provide a commentary @BloodJournal on the exciting data with dual epigenetic targeting with chidamide and decitabine in combination with an anti-PD1 antibody in heavily pre-treated r/r cHL: authors.elsevier.com/a/1k0%7Ea1UYwn…

Grateful for the opportunity to provide a commentary @BloodJournal on the exciting data with dual epigenetic targeting with chidamide and decitabine in combination with an anti-PD1 antibody in heavily pre-treated r/r cHL: authors.elsevier.com/a/1k0%7Ea1UYwn…
Ankur Singh (@dr_asingh) 's Twitter Profile Photo

"Human Immune Organoids & Organs-on-Chip" - Excited to share our new work Nature Materials! Congrats to PhD student Monica Zhong for leading this breakthrough work & to all authors!👏🏽Immense thanks to Wellcome Leap & @NIAIDFunding, National Cancer Institute + for support!🙏🏽nature.com/articles/s4156…

"Human Immune Organoids &amp; Organs-on-Chip" - Excited to share our new work <a href="/NatureMaterials/">Nature Materials</a>! Congrats to PhD student <a href="/MonicaZhong5/">Monica Zhong</a> for leading this breakthrough work &amp; to all authors!👏🏽Immense thanks to <a href="/WellcomeLeap/">Wellcome Leap</a> &amp; @NIAIDFunding, <a href="/theNCI/">National Cancer Institute</a> + for support!🙏🏽nature.com/articles/s4156…
MSK CME (@mskcme) 's Twitter Profile Photo

We invite the submission of abstracts in #PediatricOncology and #DevelopmentalOncology in the areas of clinical, translational, or fundamental research. Selected abstracts will be featured as live oral presentations at the 2025 Robert Steel Symposium in Developmental Oncology,

We invite the submission of abstracts in #PediatricOncology and #DevelopmentalOncology in the areas of clinical, translational, or fundamental research. Selected abstracts will be featured as live oral presentations at the 2025 Robert Steel Symposium in Developmental Oncology,
Jonathan Friedberg (@drjfriedberg) 's Twitter Profile Photo

Pleased that our SWOG Cancer Research Network S1826 trial (Nivolumab+AVD in advanced stage classic Hodgkin lymphoma) made the NEJM 2024 Notable Article collection; a testimony to everyone involved in this impactful trial (particularly the patients who participated).

MSK CME (@mskcme) 's Twitter Profile Photo

On behalf of Kentsis Research Group, we invite the submission of #abstracts for the 2025 Robert Steel Symposium in Developmental Oncology Memorial Sloan Kettering Cancer Center. Abstracts will be selected for live oral presentations during this year's exciting event, taking place May 19–20 in New York City.

Weill Cornell Pediatrics (@wcmpeds) 's Twitter Profile Photo

🎉 Huge congrats to Dr. Jaclyn Rosenzweig of #NYPKomansky of Children’s Hospital of New York for being named a recipient of the Hyundai Hope On Wheels Young Investigator Award! NewYork-Presbyterian @weillcornell Sallie Permar MD PhD Anita Mesi

🎉 Huge congrats to Dr. Jaclyn Rosenzweig of #NYPKomansky of Children’s Hospital of New York for being named a recipient of the Hyundai Hope On Wheels Young Investigator Award! <a href="/nyphospital/">NewYork-Presbyterian</a> @weillcornell <a href="/SalliePermar/">Sallie Permar MD PhD</a> <a href="/MesiAnita/">Anita Mesi</a>
MSK CME (@mskcme) 's Twitter Profile Photo

Join us for a complimentary, in-person symposium Memorial Sloan Kettering Cancer Center to explore the latest research and innovative treatments tailored to the distinct needs of the adolescent and young adult (#AYA) cancer population: bit.ly/AYASymposium20… The symposium will focus on 3 core

Join us for a complimentary, in-person symposium <a href="/MSKCancerCenter/">Memorial Sloan Kettering Cancer Center</a> to explore the latest research and innovative treatments tailored to the distinct needs of the adolescent and young adult (#AYA) cancer population: bit.ly/AYASymposium20…

The symposium will focus on 3 core
Vijay Sankaran (@bloodgenes) 's Twitter Profile Photo

Check out this fantastic plenary paper from Kai Tan Lab and colleagues in Blood Journal: tinyurl.com/mr9nzj3k Michael Poeschla and I had the privilege to write a commentary, "Getting to the root of high-risk leukemias" tinyurl.com/htf3e8d2

Check out this fantastic plenary paper from <a href="/KaiTanLab1/">Kai Tan Lab</a> and colleagues in <a href="/BloodJournal/">Blood Journal</a>: tinyurl.com/mr9nzj3k

<a href="/michaelpoeschla/">Michael Poeschla</a> and I had the privilege to write a commentary, "Getting to the root of high-risk leukemias" tinyurl.com/htf3e8d2
Toby Eyre (@tobyeyre82) 's Twitter Profile Photo

Nivolumab-AVD Versus Brentuximab Vedotin–AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826 | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…

NYU Langone Health (@nyulangone) 's Twitter Profile Photo

Welcoming Dr. John P. Leonard as chief of the Division of Hematology & Medical Oncology and director of the Center for Blood Cancers at Perlmutter Cancer Center at NYU Langone Health! A global leader in lymphoma care, he brings decades of research and clinical expertise. Learn more: bit.ly/46eRupF

Welcoming Dr. John P. Leonard as chief of the Division of Hematology &amp; Medical Oncology and director of the Center for Blood Cancers at <a href="/Perlmutter_CC/">Perlmutter Cancer Center at NYU Langone Health</a>! A global leader in lymphoma care, he brings decades of research and clinical expertise.

Learn more: bit.ly/46eRupF